NCT06630754

Brief Summary

The primary aim of the study is to explore body composition in older adults (aged 70 years and over) with cancer, undergoing systemic anticancer treatment. Additional aims include to explore the extent of body composition changes and whether changes are tumour specific, the incidence for cancer-related cachexia and sarcopenia and finally, how body composition can inform nutritional management of older adults with cancer. To do this, the investigators applied for and were awarded funding from a company called Nutricia to pay for a band 4 (0.6 WTE for 7 months) to take monthly body composition measures on the patients who are eligible, accepting of assessment by the Senior Adult Oncology Programme (SAOP) and consent to these measures. Measurements will include an analysis from the Bioelectrical Impedance Analysis (BIA) machine which will quantify fat, lean muscle, and water content; waist to hip ratio; handgrip strength; calf circumferences. Socio-demographic data will also be collected. Descriptive data analysis will take place to explore possible trends and associations which may inform future research and drive even further personalised care for this growing and typically underrepresented in research, population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

September 19, 2024

Last Update Submit

October 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Explore body composition in older adults with cancer starting SACT.

    means and standard deviations (or medians and interquartile ranges if not normally distributed) of body composition measures taken from all participants at baseline/ first Research Clinic, analysed at end of study will quantify this objective.

    7 months

Secondary Outcomes (1)

  • Explore the extent of body composition changes in older adults with cancer during SACT.

    7 months

Other Outcomes (3)

  • Explore whether there are differences between body composition in older adults with cancer receiving SACT, based on tumour diagnosis

    7 months

  • Explore how body composition can inform nutritional management of older adults with cancer receiving SACT.

    7 months

  • Investigate the incidence for cancer-related cachexia and sarcopenia in older adults with cancer receiving SACT.

    7 months

Study Arms (1)

adults aged 70yrs and older, eligible, and accepting of assessment in the SAOP.

Other: No Intervention: Observational Cohort

Interventions

No intervention; observation cohort study

adults aged 70yrs and older, eligible, and accepting of assessment in the SAOP.

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adults aged 70 years and older, with a cancer diagnosis who are to receive systemic anti-cancer treatment

You may qualify if:

  • Adults eligible and accepting of assessment in the SAOP.
  • adults aged 70 years and over
  • a cancer diagnosis
  • just starting SACT
  • able to provide at least 2 data sets during the study period (baseline + at least 1 research clinic visit)
  • willing and able to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Marsden Hospital

London, SM2 5PT, United Kingdom

Location

MeSH Terms

Conditions

CachexiaNeoplasmsSarcopenia

Condition Hierarchy (Ancestors)

Weight LossBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsThinnessMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Study Officials

  • Lucy Eldridge, M.Sc. (Hons) Cancer Care Award

    Royal Marsden NHS Foundation Trust

    STUDY DIRECTOR
  • Megan Pattwell, PGDip Dietetics

    Royal Marsden NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lucy Eldridge, M.Sc. (Hons) Cancer Care Award

CONTACT

Megan Pattwell, PGDip Dietetics

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2024

First Posted

October 8, 2024

Study Start

November 1, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

October 8, 2024

Record last verified: 2024-10

Locations